A Study of response to Burkholdaria cepacia
DOI:
https://doi.org/10.36320/ajb/v9.i2.7603Keywords:
Burkholderia cepacia, OMP, Immune response, Heat killed whole cell antigenAbstract
The current study was aimed to evaluate immune response induced by Burkholdaria cepacia antigens to determine whether these antigens could be a useful immunogen for vaccine development against this bacteria. Four successive doses of OMP and killed antigen extracted from B. cepacia isolated from sputum of patients with lower respiratory tract infections were injected into rabbits using multisite injection protocol. We found that these antigens stimulate specific mucosal and systemic humoral immunoglobulin titers as well as to the significant increased (p≤ 0.05) in the total protein concentrations at serum and mucosal respiratory secretions in addition to the significant increase in the concentrations of IgG, IgA, IgM at rabbits sera. INF-γ concentrations were significant increased at serum and mucosal levels with stimulation of migration inhibition index of leukocytes. These immunogen induced positive skin test tuberculin type delayed hypersensitivity. Thus B. cepacia antigens were B and T cells dependent type, and could be a useful immunogen for vaccine development.
Downloads
References
Sousa, S.A. ; Ramos, C. G. and Leitao, J. H. (2011). Burkholderia cepacia Complex: Emerging Multihost Pathogens Equipped with a Wide Range of Virulence Factors and Determinants. International J. Microbiol. ID 607575, 9 P.
Govan, J. R. W.; Hughes, J. E. and Vandamme, P. (1996). Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol. 45:395–407.
Wigfield, S. M.; Rigg, G. P.; Kavair, M.; Webb, A. K.; Matthews, R. C. and Burnie, J. P. (2002). Identification of an immunodominant drug efflux pump in Burkholderia cepacia. J. Antimicrob. Chemother. 2002;49:619–624.
Hauserm N. and Orsini, J. (2015). Cepacia Syndrome in a Non-Cystic Fibrosis Patient. Case Reports in Infectious Diseases. ID 537627, 4 p.
Lacy, D. E. 1.; Smith, A. W.; Stableforth, D. E.; Smith, G.; Weller, P. H. and Brown, M. R. (1995). Serum IgG response to Burkholderia cepacia outer membrane antigens in cystic fibrosis: assessment of cross-reactivity with Pseudomonas aeruginosa. FEMS Immunol Med Microbiol. 10(3-4):253-61.
George, A. M.; Jones, P. M., and Middleton, P.G.(2009). Cystic fibrosis infections: treatment strategies and prospects. FEMS Microbiol. Lett. 300, 153–164.
Fisher, M. C.; LiPuma, J. J.; Dasen, S. E.; Caputo, G. C.; Mortensen, J. E.; McGowan, K. L. and Stull, T. L. (1993). Source of Pseudomonas cepacia: Ribotyping of isolates from patients and from the environment. J Pediatr. 123: 745-747.
Mahenthiralingam, E.; Baldwin, A. and Dowson, C. G. (2008). Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology. J Appl Microbiol. 104(6):1539-51.
Leang-Chung, C.; Guang-Han, O.; Kumutha, M.V.; Kaveena, K.; Wen-Tyng, K.; Al-Maleki A. R.; Vanitha, M. and Jamuna V. (2013). Burkholderia vaccines: are we moving forward? Front. Cell. Infect. Microbiol, Malaysia.
Hara, Y.; Mohamed, R. and Nathan, S. (2009). Immunogenic Burkholderia pseudomallei Outer Membrane Proteins as Potential Candidate Vaccine Targets. PLOS ONE. 4( 8). e6496.
Makidon, P. E., Knowlton, J., Groom, J. V. 2nd, Blanco, L. P., Lipuma, J. J., Bielinska, A. U., et al. (2010). Induction of immune response to the 17 kDa OMPA Burkholderia cenocepacia polypeptide and protection against pulmonary infection in mice after nasal vaccination with an OMP nanoemulsion-based vaccine. Med. Microbiol. Immunol. 199, 81–92.
Mariappana, V.; Vellasamya, K. M.; Thimmaa, J. S.; Hashim O. H. and Vadivelua, J. (2010). Identification of immunogenic proteins from Burkholderia cepacia secretome using proteomic analysis. 28. 1318–1324.
Forbes, B. A.; Daniel, F. S. and Alice, S. W. (2007). Baily and Scotťs Diagnostic microbiology. 12thed. Mosby. Elsevier Company, USA.
MacFadden, J. F. (2000). Biochemical tests for the identification of medical bacteria. 3rd Ed. The Williams and Wilkins- Baltimor, USA.
Carlone, G. M.; Thomas, M.; Rumschlag, H. and Sottnek, F. (1986). Rapid micro procedure for isolation detergent insoluble OMP. From Hib Clin. Microb. J. 24(3): 330 - 332.
Svanborg-Eden, C. ; Kulhary, R. and Martid, S. (1985). Urinary immunoglobulin in healthy individuals and children with acute pyelonephritis. Scand. J. Immunol., 21: 305-313.
Sachse, F. ; Ahlers, F. ; Stoll, W. & Rudack, C. (2005). Neutrophil chemokines in epithelial inflammatory processes of human tonsils. Clin. Exp. Immunol. , 140:293-300.
Schneider, E. ; Volecker, G. and Hsude, W. (1990). Age and set dependent on phospholipids concentration in human erythrocyte. I. Z. Med. Lab. Dia. 31: 86-89.
Shnawa, I. M. S. and Thewaini, Q. N. A.(2001). Benzlmidazol carbamate pesticide pollution immunology: 1 - the benomyl dose dependent humoral immune suppression of rabbits immunized with egg albumin combination. J. Bab. Univ. 6 (3): 401 - 406.
Al-Thahab, A. A. L. (2006). Cryptic Meningitis and Some Aspects of its Local and Systemic Immunity. Ph.D, thesis. Babylon University. Iraq (In Arabic).
Shnawa, I.M.S. and Thwaini ,Q.N.A.(2002). Lapin mucosal humoral versus systemic humoral and cellular immune response post to intratesticular administration of heat killed campylobacter fetus bacteria .J. Babylon. Sci. Appl.3:58-542
Garvey, J.S. ; Cremer, N. E. and Sussdrof, D. H. (1977). Methods in Immunology . 3th ed., Addison-Wesley Publishing Company. Inc., Reading : 53-267.
Shnawa, I.M.S. and Abid, F.G. (2005). The role of carbohydrate binding complement components. The lactins in plotting the immunophyltic tree of vertebrate. Al-Qadisiya J. Vet. Med. Sic., 4:1-5.
LiPuma, J.J.; Spilker, T.; Coenye, T. and Gonzalez, C.F.(2002). An epidemic Burkholderia cepacia complex strain identified in soil. Lancet. 8:359. 9322.
Reddy, K.R. (2010). Microbiology and Parasitology .4th ed., Paras Medical Publisher , New Delhi.
Bertot, M.B. ; Marcela, A.R. ; Laura, G. ; Rene, C.A.U. ; Miguel, A.V. and Sau´l, G. (2007). Nasal Immunization with Burkholderia multivorans Outer Membrane Proteins and the Mucosal Adjuvant Adamantylamide Dipeptide Confers Efficient Protection against Experimental Lung Infections with B. multivorans and B. cenocepacia. Infection & Immunity, Vol. 75, No. 6, p. 2740–2752.
Williams, R. C. and R. J. Gibbons. (1972). Inhibition of bacterial adherence by secretory immunoglobulin A: a mechanism of antigen disposal. Science 177:697–699.
Aronoff, S. C. and Stern, R. C. (1988). Serum IgG Antibody to Outer Membrane Antigens of Pseudomonas cepacia and Pseudomonas aeruginosa in Cystic Fibrosis. J Infect Dis . 157(5):934-40
Michetti, P. (2011). Prophylactic and therapeutic immunization gastric Helicobacter pylori infection. Pasteur Institute Euroconferences, J. Infect. and Dig. Tr. Dis.,1:1-4.
Speert DP , Steen B, Halsey K, Kwan E. A. (1999). murine model for infection with Burkholderia cepacia with sustained persistence in the spleen. Infect. Immun. 67(8): 4027-4032.
Daniel W. Martin, D.W. and and Mohr, C. D. (2000). Invasion and Intracellular Survival of Burkholderia cepacia. Infect Immun. 2000 Jan; 68(1): 24–29.
Al – Jebory, S.A.K. (2012). Effect of Induction of Local and Systemic on Immune Response of Helicobacter pylori Antigen in Rabbits. College of Science, University of Babylon. Ph.D. Thesis. ( In Arabic).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Alaa Fahim Abbas, Samah Ahmed Kadum
This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.
